Literature DB >> 1732569

The pharmacokinetics of prophylactic antibiotics in trauma.

R L Reed1, C D Ericsson, A Wu, P Miller-Crotchett, R P Fischer.   

Abstract

Despite prophylactic antibiotic use in abdominal trauma patients, infection rates remain high. A previous study from our institution indicated that higher doses of prophylactic antibiotics in trauma patients could significantly reduce subsequent infection rates. To determine if this resulted from altered pharmacokinetic profiles, we performed individualized pharmacokinetic analysis of the prophylactic amikacin regimens given to 28 trauma patients undergoing laparotomy. Patients were prospectively randomized to receive a standard regimen of 11 mg/kg of amikacin every 12 hours or to have their regimens adjusted based upon pharmacokinetic analysis. Repeated pharmacokinetic analyses were performed daily for the three-day prophylactic regimen. There was a significant expansion in the apparent volume of distribution for amikacin that correlated with fluid resuscitation. This, along with increased elimination rates, helps to explain the failure to achieve adequate amikacin levels using standard regimens in trauma patients. Such underdosing may contribute to relatively high infection rates following major abdominal injury.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1732569     DOI: 10.1097/00005373-199201000-00005

Source DB:  PubMed          Journal:  J Trauma        ISSN: 0022-5282


  5 in total

Review 1.  Individualising aminoglycoside dosage regimens after therapeutic drug monitoring: simple or complex pharmacokinetic methods?

Authors:  M M Tod; C Padoin; O Petitjean
Journal:  Clin Pharmacokinet       Date:  2001       Impact factor: 6.447

2.  Surgical strategies for management of the open abdomen.

Authors:  Justin L Regner; Leslie Kobayashi; Raul Coimbra
Journal:  World J Surg       Date:  2012-03       Impact factor: 3.352

3.  Population pharmacokinetics of meropenem in critically ill patients undergoing continuous renal replacement therapy.

Authors:  Arantxazu Isla; Alicia Rodríguez-Gascón; Iñaki F Trocóniz; Lorea Bueno; María Angeles Solinís; Javier Maynar; José Angel Sánchez-Izquierdo; José Luis Pedraz
Journal:  Clin Pharmacokinet       Date:  2008       Impact factor: 6.447

4.  Planned re-laparotomy and the need for optimization of physiology and immunology.

Authors:  L Kobayashi; R Coimbra
Journal:  Eur J Trauma Emerg Surg       Date:  2014-03-27       Impact factor: 3.693

5.  Recommended β-lactam regimens are inadequate in septic patients treated with continuous renal replacement therapy.

Authors:  Lucie Seyler; Frédéric Cotton; Fabio Silvio Taccone; Daniel De Backer; Pascale Macours; Jean-Louis Vincent; Frédérique Jacobs
Journal:  Crit Care       Date:  2011-06-06       Impact factor: 9.097

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.